Skip to content

Ep. 123 - Gilde’s Joep Muijrers on why patients belong in the investment process

October 30, 2026 · 34 min

Show notes

On this edition of The BioCentury Show, Gilde's Joep Muijrers joins BioCentury’s Stephen Hansen to discuss how the firm’s Impact Council of former regulators, payers, HTA leaders, and patient advocates shapes its investment decisions. Muijrers explains how council input steered Gilde away from one deal and toward another, diagnostics company Karius, and why he argues patient perspectives belong alongside physician input in diligence and development strategy. He also describes the frameworks Gilde has developed for engaging patient organizations, and why he urges other investors to adopt them as a pre-competitive practice. This episode of The BioCentury Show is brought to you by Tigermed.

View full story: https://www.biocentury.com/article/661356

#PatientEngagement #BiotechInvesting #ImpactInvesting #VentureCapital #MarketAccess

0:00 Introduction
2:00 Creating Gilde's Impact Council
7:32 Advisors' Impact on Investing
16:42 Gilde's Approach to Patient Engagement
23:50 Where Patient Input Fits in Decision-making
29:17 Why Other Investors Should Engage

All episodes of The BioCentury Show

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.